DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo



company name or ticker
Company Photos
(Click to zoom)

Mid-Afternoon Market Update: Markets Turn Red as Tesla Continues to Rip Higher

Tuesday Sector Leaders: Biotechnology, Apparel Stores

Why InterMune Inc. Shares Exploded Higher By More Than 170%

InterMune shares soared after the company released positive late-stage trial data. Should investors jump on this runaway train or stay as far away from the tracks as possible?

InterMune Lung Treatment Brings Buyout Gains, Without A Buyout

Today's Biggest Biotech Stories: BioCryst, Verastem, and InterMune

BioCryst, Verastem, and InterMune could all loom large in health care headlines this morning. Here's why.

Today's Pre-Market Mover With Heavy Volume: InterMune (ITMN)

InterMune Hits Home Run With Pivotal Lung Drug Study Results

InterMune (ITMN) Shares Cross Below 200 DMA

Biotech Stock Mailbag: InterMune, Ohr Pharma, Ampio

InterMune Is Set To Outperform Its Main Competitor

See More Articles...